{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T09:44:50Z","timestamp":1747388690079},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/2050-7771-2-7","type":"journal-article","created":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T07:03:21Z","timestamp":1396335801000},"source":"Crossref","is-referenced-by-count":4,"title":["A rare case of primary cutaneous follicle centre lymphoma presenting as a giant tumour of the scalp and combined with JAK2V617F positive essential thrombocythaemia"],"prefix":"10.1186","volume":"2","author":[{"given":"Yordanka","family":"Tirefort","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan-Cuong","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmine Lucile","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas Pierre","family":"Lecompte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Matthes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christa","family":"Prins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Begonia","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bernimoulin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Chalandon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaveh","family":"Samii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,1]]},"reference":[{"key":"37_CR1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1182\/blood-2006-10-054601","volume":"110","author":"YH Kim","year":"2007","unstructured":"Kim YH, Willemze R, Pimpinelli N, Whittaker S, Olsen EA, Ranki A, Dummer R, Hoppe RT: TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007, 110: 479\u2013484. 10.1182\/blood-2006-10-054601","journal-title":"Blood"},{"key":"37_CR2","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/j.1365-2133.2006.07264.x","volume":"154","author":"JD Bouaziz","year":"2006","unstructured":"Bouaziz JD, Bastuji-Garin S, Poszepczynska-Guign\u00e9 E, Wechsler J, Bagot M: Relative frequency and survival of patients with primary cutaneous lymphomas: data from a single-centre study of 203 patients. Br J Dermatol 2006, 154: 1206\u20131207. 10.1111\/j.1365-2133.2006.07264.x","journal-title":"Br J Dermatol"},{"key":"37_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000342484","volume":"129","author":"G Hauck","year":"2013","unstructured":"Hauck G, Jonigk D, Kreipe H, Hussein K: Simultaneous and sequential concurrent myeloproliferative and lymphoproliferative neoplasms. Acta Haematol 2013, 129: 187\u2013196. 10.1159\/000342484","journal-title":"Acta Haematol"},{"key":"37_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000204848","volume":"85","author":"NY Gabrail","year":"1991","unstructured":"Gabrail NY, Martin TW: Coexistence of essential thrombocythemia and chronic lymphocytic leukemia. Acta Haematol 1991, 85: 31\u201333. 10.1159\/000204848","journal-title":"Acta Haematol"},{"key":"37_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3109\/10428190009148865","volume":"36","author":"JC Hern\u00e1ndez-Boluda","year":"2000","unstructured":"Hern\u00e1ndez-Boluda JC, Cervantes F, Alvarez A, L\u00f3pez-Guillermo A, Montserrat E: Non-Hodgkin\u2019s lymphoma following untreated essential thrombocythemia. Leuk Lymphoma 2000, 36: 421\u2013423. 10.3109\/10428190009148865","journal-title":"Leuk Lymphoma"},{"key":"37_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/10428190802713521","volume":"50","author":"F Palandri","year":"2009","unstructured":"Palandri F, Derenzini E, Ottaviani E, Polverelli N, Catani L, Salmi F, Sabattini E, Bacci F, Zinzani PL, Baccarani M, Vianelli N: Association of essential thrombocythemia and non-Hodgkin lymphoma: a single-centre experience. Leuk Lymphoma 2009, 50: 481\u2013484. 10.1080\/10428190802713521","journal-title":"Leuk Lymphoma"},{"key":"37_CR7","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1158\/1055-9965.EPI-09-0353","volume":"18","author":"AM Vannucchi","year":"2009","unstructured":"Vannucchi AM, Masala G, Antonioli E, Chiara Susini M, Guglielmelli P, Pieri L, Maggi L, Caini S, Palli D, Bogani C, Ponziani V, Pancrazzi A, Annunziato F, Bosi A: Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Cancer Epidemiol Biomarkers Prev 2009, 18: 2068\u20132073. 10.1158\/1055-9965.EPI-09-0353","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"37_CR8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3324\/haematol.2010.033779","volume":"96","author":"E Rumi","year":"2011","unstructured":"Rumi E, Passamonti F, Elena C, Pietra D, Arcaini L, Astori C, Zibellini S, Boveri E, Pascutto C, Lazzarino M: Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients . Haematologica 2011, 96: 454\u2013458. 10.3324\/haematol.2010.033779","journal-title":"Haematologica"},{"key":"37_CR9","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/ajh.22171","volume":"86","author":"L Laurenti","year":"2011","unstructured":"Laurenti L, Tarnani M, Nichele I, Ciolli S, Cortelezzi A, Forconi F, Rossi D, Mauro FR, D'Arena G, Del Poeta G, Montanaro M, Morabito F, Musolino C, Callea V, Falchi L, Tedeschi A, Ambrosetti A, Gaidano G, Leone G, Fo\u00e0 R: The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experience. Am J Hematol 2011, 86: 1007\u20131012. 10.1002\/ajh.22171","journal-title":"Am J Hematol"},{"key":"37_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/10428190500271723","volume":"47","author":"JW Lee","year":"2006","unstructured":"Lee JW, Soung YH, Kim SY, Nam SW, Park WS, Lee JY, Yoo NJ, Lee SH: JAK2 V617F mutation is uncommon in non-Hodgkin lymphomas. Leuk Lymphoma 2006, 47: 313\u2013314. 10.1080\/10428190500271723","journal-title":"Leuk Lymphoma"},{"key":"37_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000111532","volume":"118","author":"YL Wang","year":"2007","unstructured":"Wang YL, Lee JW, Kui JS, Chadburn A, Cross NC, Knowles DM, Coleman M: Evaluation of JAK2V617F in B and T cell neoplasms: identification of JAK2V617F mutation of undetermined significance (JMUS) in the bone marrow of three individuals. Acta Haematol 2007, 118: 209\u2013214. 10.1159\/000111532","journal-title":"Acta Haematol"},{"key":"37_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1179\/102453308X316022","volume":"13","author":"F Radaelli","year":"2008","unstructured":"Radaelli F, Onida F, Rossi FG, Zilioli VR, Colombi M, Usardi P, Calori R, Zanella A: Second malignancies in essential thrombocythemia (ET): a retrospective analysis of 331 patients with long-term follow-up from a single institution. Hematology 2008, 13: 195\u2013202. 10.1179\/102453308X316022","journal-title":"Hematology"},{"key":"37_CR13","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","volume":"116","author":"MR Green","year":"2010","unstructured":"Green MR, Monti S, Rodig SJ, Juszczynski P, Currie T, O'Donnell E, Chapuy B, Takeyama K, Neuberg D, Golub TR, Kutok JL, Shipp MA: Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Blood 2010, 116: 3268\u20133277. 10.1182\/blood-2010-05-282780","journal-title":"Blood"},{"key":"37_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJMra1202117","volume":"368","author":"JJ O'Shea","year":"2013","unstructured":"O'Shea JJ, Holland SM, Staudt LM: JAKs and STATs in immunity, immunodeficiency, and cancer. N Engl J Med 2013, 368: 161\u2013170. 10.1056\/NEJMra1202117","journal-title":"N Engl J Med"},{"key":"37_CR15","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1517\/13543784.2013.775244","volume":"22","author":"E Derenzini","year":"2013","unstructured":"Derenzini E, Younes A: Targeting the JAK-STAT pathway in lymphoma: a focus on pacritinib. Expert Opin Investig Drugs 2013, 22: 775\u2013785. 10.1517\/13543784.2013.775244","journal-title":"Expert Opin Investig Drugs"},{"key":"37_CR16","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1517\/13543784.2013.774373","volume":"22","author":"CS Tam","year":"2013","unstructured":"Tam CS, Verstovsek S: Investigational Janus kinase inhibitors. Expert Opin Investig Drugs 2013, 22: 687\u2013699. 10.1517\/13543784.2013.774373","journal-title":"Expert Opin Investig Drugs"},{"key":"37_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/2050-7771-1-5","volume":"1","author":"M Furqan","year":"2013","unstructured":"Furqan M, Mukhi N, Lee B, Liu D: Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application. Biomark Res 2013, 1: 5\u201315. 10.1186\/2050-7771-1-5","journal-title":"Biomark Res"},{"key":"37_CR18","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1200\/JCO.2012.42.5223","volume":"30","author":"A Younes","year":"2012","unstructured":"Younes A, Romaguera J, Fanale M, McLaughlin P, Hagemeister F, Copeland A, Neelapu S, Kwak L, Shah J, de Castro Faria S, Hart S, Wood J, Jayaraman R, Ethirajulu K, Zhu J: Phase I study of a novel oral Janus Kinase 2 inhibitor, SB1518, in patients with relapsed lymphoma: evidence of clinical and biologic active ty in multiple lymphoma subtypes. J Clin Oncol 2012, 30: 4161\u20134167. 10.1200\/JCO.2012.42.5223","journal-title":"J Clin Oncol"},{"key":"37_CR19","first-page":"282","volume":"118","author":"R Komrokji","year":"2011","unstructured":"Komrokji R, Wadleigh M, Seymour J, Roberts A, To L, Zhu H, Mesa R: Results of a phase 2 study of pacritinib (SB1518), a novel oral JAK2 inhibitor, in patients with primary, post-polycythemia vera, and post-essential thrombocythemia myelofibrosis [abstract]. ASH Annual Meeting Abstracts 2011, 118: 282.","journal-title":"ASH Annual Meeting Abstracts"},{"issue":"Suppl","key":"37_CR20","doi-asserted-by":"crossref","first-page":"6515","DOI":"10.1200\/jco.2011.29.15_suppl.6515","volume":"29","author":"H Deeg","year":"2011","unstructured":"Deeg H, Odenike O, Scott B, Estrov Z, Cortes J, Thomas D, Zhu J, Kantarjian H, Verstovsek S: Phase II study of SB1518, an orally available novel JAK2 inhibitor, in patients with myelofibrosis [abstract]. J Clin Oncol 2011,29(Suppl):6515.","journal-title":"J Clin Oncol"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2050-7771-2-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T13:38:07Z","timestamp":1548164287000},"score":1,"resource":{"primary":{"URL":"https:\/\/biomarkerres.biomedcentral.com\/articles\/10.1186\/2050-7771-2-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["37"],"URL":"https:\/\/doi.org\/10.1186\/2050-7771-2-7","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,1]]},"article-number":"7"}}